THE 5th INTERNATIONAL HEART HEALTH CONFERENCE
	Positioning Technology to Serve Global Heart Health
	Milan, Italy, June 13-16, 2004

Program
Sunday, June 13		Monday, June 14			P O S T E R E X H I B I T I O N	Tuesday, June 15			Wednesday, June 16
08:30		Plenary Session 1				Plenary Session 3			Plenary Session 5
09:00
09:30
10:00
10:30		Parallel Session 1	Parallel Session 2	Parallel Session 3		Parallel Session 1	Parallel Session 2	Parallel Session 3	Coffee Break
11:00									Closing Plenary Session
11:30		Coffee Break
12:00		Parallel Session 4	Parallel Session 5	Satellite Symposium		Parallel Session 4	Parallel Session 5	Abstract Session 1	Milan Declaration
12:30
13:00		Lunch Moderated Poster Session				Luncheon Panel
13:30	Satellite Symposium
14:00		Plenary Session 2				Plenary Session 4
14:30
15:00	Coffee Break
15:30	Satellite Symposium
16:00		Parallel Session 1	Parallel Session 2	Parallel Session 3		Parallel Session 1	Parallel Session 2	Parallel Session 3
16:30
17:00		Coffee Break				Coffee Break
17:30	OPENING CEREMONY and WELCOME RECEPTION	Parallel Session 4	Parallel Session 5	Parallel Session 6		Parallel Session 4	Satellite Symposium	Abstract Session 2
18:00

Main Scientific Program - Room: Caravella S. Maria
Sunday, June 13
13:30 – 15:00	Satellite Symposium (back) (Unrestricted Educational Grant by Bayer Canada) THE PREVENTION AND CONTROL OF CARDIOVASCULAR DISEASE: LESSONS FROM THE CANADIAN HEART HEALTH INITIATIVE
	Co-Chairs: D. R. MacLean (Canada); B. O’ Connor (Canada)
	Hypertension Management & Control in Canada and Europe
	M. Joffres (Canada)
	Benefits of Professional Education for Cardiovascular Disease Prevention and Control: “The Healthy Heart Kit”
	A. Chockalingam (Canada)
	A Case for Integrated Chronic Disease Management
	D. R. MacLean (Canada)
	Blood Pressure: the Public Health Challenge
	B. O’ Connor (Canada)
15:00 – 15:30	COFFEE BREAK
15:30 – 18:00	Satellite Symposium (back) (Unrestricted Educational Grant by Bayer HealthCare LLC) ASPIRIN FOR THE GLOBAL PREVENTION OF CARDIOVASCULAR DISEASE – CLINICAL EVIDENCE, ISSUES, AND RECOMMENDATIONS
	Chair: C. H. Hennekens (USA)
	Opening Remarks
	C. H. Hennekens (USA)
	A Review of the Randomized Evidence Supporting the Use of Low-Dose Aspirin in the Primary and Secondary Prevention of Cardiovascular Disease
	C. H. Hennekens (USA)
	An Overview of Safety Issues and Patient Selection Regarding the Chronic Use of Low-Dose Aspirin in the Prevention of Cardiovascular Disease
	M. Pignone (USA)
	The Under-Utilization of Aspirin and Other Cardiovascular Prevention Therapies on a Global Scale
	R. S. Stafford (USA)
	The Cost-Effectiveness of Aspirin in Comparison to Other Therapies in Cardiovascular Disease Prevention
	M. Pignone (USA)
	Panel Discussion and Summary: Recommendations for the Use of Low-Dose Aspirin on a Global Scale for Cardiovascular Disease Prevention
	C. H. Hennekens (USA)
	OPENING CEREMONY and WELCOME RECEPTION

Monday, June 14
08:30 – 09:40	Plenary Session 1 (back) Global Heart Health: The Challenge Before Us
	Co-Chairs: P. Puska (Finland); A. Chockalingam (Canada)
	The Health of Populations
	J. Mackay, Hong Kong (China)
	Technology and the Health of Populations: Forces to be Reckoned With
	J. P. Koplan (USA)
	Heart Health in the World Today: Challenges and Opportunities
	D. R. Labarthe (USA)
11:05 – 11:35	COFFEE BREAK
12:50 – 13:50	LUNCH
13:20 – 13:50	Moderated Poster Session (back) (Promoted by the International Society for Mathematical Models in Medicine) – Room Leonardo
	WHAT MATHEMATICS CAN SAY ABOUT HEART HEALTH, WHAT MATHEMATICIANS WOULD LIKE TO PROPOSE
13:50 – 15:00	Plenary Session 2 (back) Putting Information Technology to Work for Global Heart Health
	Co-Chairs: T. A. Pearson (USA);  D. Cianflone (Italy)
	Implementing Cardiovascular Prevention Through Technology: Fact or Fiction
	M. Pagani (Italy)
	The European Efforts in Promoting e-Health
	A. Lymberis (EU)
	Developing the Heart Healthy Home
	A. Pentland (USA)
16:25 – 16:55	COFFEE BREAK

Tuesday, June 15
08:30 – 09:40	Plenary Session 3 (back) Biotechnology: Evaluating the Potential
	Co-Chairs: D. Cianflone (Italy);  T. A. Pearson (USA)
	Biotechnology Without Borders: Can Discovery Benefit All?
	G. Schreiner (USA)
	Upcoming Diagnostics in Biotechnology
	C. Bordignon (Italy)
	The Role of Information Technology in Healthcare and Life Sciences: Information Based Medicine
	M. Hehenberger (USA)
11:05 – 11:35	COFFEE BREAK
12:50 – 13:50	Luncheon Panel (back) (Unrestricted Educational Grant by Sanofi-Synthelabo) – Room A and B
	A NOVEL APPROACH IN THE MANAGEMENT OF GLOBAL CARDIOVASCULAR RISK
	Chair: T. A. Pearson (USA)
	Intervention in CV Risk Reduction: Modifiable Risk Factors and Missed Prevention Opportunities
	D. Vanuzzo (Italy)
	Targeting the Cause of Clustering Risk Factors: Promising Opportunities
	L. Van Gaal (Belgium)
13:50 – 15:00	Plenary Session 4 (back) Technology and Heart Health: Lessons Learned
	Co-Chairs: R. Beaglehole (Switzerland); M. Maranhao (Brazil)
	25 Years of Cardiovascular Trials: Implications for Health Technology
	R. Peto (UK)
	Information Technology and Implementation of the First Global Public Health Treaty
	D. Yach (Switzerland)
	Cardiovascular Disease Prevention and Control in Developing Countries, Challenges and Opportunities
	S. Mendis (Switzerland)
16:25 – 16:55	COFFEE BREAK

Wednesday, June 16
08:30 – 10:00	Plenary Session 5 (back) Perspective on the Future of Global Heart Health
	Co-Chairs: S. Stachenko (Canada); D. R. MacLean (Canada)
	A Cardiologist’s Perspective on the Crisis and Challenges of Technology in Health
	B. E. Lown (USA)
	Personalized Prevention
	A. Maseri (Italy)
	Strategic Pathways to Global Heart Health: How Can We Telescope the Transition?
	S. Reddy (India)
	Global Heart Health: Challenge Before Us
	P. Puska (Finland)
10:00 – 10:30	COFFEE BREAK
10:30 – 11:30	Closing Plenary Session (back) The Way Forward
	Co-Chairs: V. Bales Harris (USA); B. O’ Connor (Canada)
	Dr. Andrés Petrasovits Tribute - A Man of Vision
	S. Stachenko (Canada)
	Announcement: Winner of CIHR-HSFC Andrés Petrasovits Fellowship
	B. McManus (Canada)
11:30 – 12:00	The Milan Declaration: Positioning Technology to Serve Global Heart Health
	D. R. MacLean (Canada)
	CLOSING REMARKS and ANNOUNCEMENT of the 6^th IHHC

Parallel Sessions Program

Monday, June 14 - Morning
09:50 – 11:05	Parallel Session 1 (back) (Sponsored by The World Health Organization) – Room Newton
	AFFORDABLE TECHNOLOGY
	Co-Chairs: R. Beaglehole (Switzerland); A. Shatchkute (Denmark)
	Using Technology for Knowledge Management
	Y. Kwankam (Switzerland)
	Policies for Appropriate Technology
	D. B. Matchar (USA)
	Affordable Technology for Primary Health Care in Developing Countries
	S. Mendis (Switzerland)
	Technical Specifications for Blood Pressure Measuring Devices and Interaction with Private Sector
	E. O' Brien (Ireland)
09:50 – 11:05	Parallel Session 2 (back) (Jointly sponsored by Health Canada and Canadian Institutes of Health Research) – Room Leonardo
	COLLABORATION ON BEST PRACTICES FOR ATTAINING GLOBAL HEART HEALTH: THE ROLE OF TECHNOLOGY AND INNOVATION
	Co-Chairs: S. Jabbour (Lebanon); F. Ofei (Ghana)
	Technology-Enabled Knowledge Creation to Knowledge Translation: Critical Issues to Consider in Research and Practice
	K. Ho (Canada);  A. Chockalingam (Canada)
	From Knowledge to Best Practices in the Age of the Internet: Mobilizing Global Forces to Answer Key Questions
	A. Jadad (Canada)
	Best Practices Systems: Ideal vs Reality – Lessons from Canadian Experience in the Global Context
	C. Clottey (Canada)
	Panel Discussion
	A. Chockalingam, C. Clottey, K. Ho, A. Jadad, S. Jabbour, F. Ofei (Ghana)
09:50 – 11:05	Parallel Session 3 (back) (Sponsored by Centers for Disease Control and Prevention) – Room Caravella S.M.
	NATIONAL ACTION PLANS FOR HEART DISEASE AND STROKE PREVENTION
	Co-Chairs: D. Zhao (China); B. Cantin (Canada)
	From North-Karelia to National Action
	E. Vartiainen (Finland)
	The National Action Plan
	S. Nishtar (Pakistan)
	A Public Health Action Plan to Prevent Heart Disease and Stroke
	D. R. Labarthe (USA)
	Panel Discussion
	E. Vartiainen, S. Nishtar, D. R. Labarthe
11:05 – 11:35	COFFEE BREAK
11:35 – 12:50	Parallel Session 4 (back) (Sponsored by The World Heart Federation) – Room Newton
	GUIDELINE DISSEMINATION
	Co-Chairs: T. A. Pearson (USA); D. Zhao (China)
	Use of Guidelines in Clinical Practice – Use of Technology
	N. Poulter (UK)
	International Guidelines for Heart Disease Prevention: Philosophy and Feasibility
	T. A. Pearson (USA)
	Guideline Development in Low and Middle Income Countries – Experience from South Asia
	S. Nishtar (Pakistan)
	Panel Discussion Co-ordinated by: R. Paoletti (Italy); TBD
11:35 – 12:50	Parallel Session 5 (back) (Sponsored by Health Canada) – Room Leonardo
	SURVEILLANCE - A DEVELOPING COUNTRY PERSPECTIVE
	Co-Chairs: A. Wielgosz (Canada); A. Ugnat (Canada)
	Surveillance in STEPS
	R. Bonita (Switzerland)
	Behaviour Risk Factor and Surveillance
	L. de Salazar (Colombia)
	Establishing Surveillance in Iran and the Middle East
	N. Sarraf-Zadegan (Iran)
	Panel Discussion
	R. Bonita, A. Ugnat, A. Wielgosz, L. de Salazar, N. Sarraf-Zadegan
11:35 – 13:05	Satellite Symposium (back) (Unrestricted Educational Grant by Laboratori Guidotti and Pfizer Italia) – Room Caravella S. M.
	PREVENTION OF CARDIOVASCULAR EVENTS WITH STATINS: FROM PHYSIOPATHOLOGIC BASES TO EVIDENCES OF CLINICAL TRIALS
	Co-Chairs: A. Maseri (Italy); D. Cianflone (Italy)
	Is it Possible to Stop Atherosclerosis Progression?
	M. Arca (Italy)
	Antiatherothrombotic Mechanisms of Statins:  the Atrocap Study Results
	M. Cortellaro (Italy)
	Treatment with Statins in Myocardial Revascularization
	A. Gaspardone (Italy)
	Evidences about the Use of Statins in the Acute Coronary Sindromes and  in the Prevention of Cerebrovascular Events
	F. Crea (Italy)
12:50 – 13:50	LUNCH

Monday, June 14 - Afternoon

15:10 – 16:25